XORTX Therapeutics, Inc. (XRTX)

1.41 -0.44 (-23.78%) USD  |  NASDAQ  |  Oct 09, 16:00
1.47 +0.06 (+4.26%) After-Hours: 20:00
More

XORTX Therapeutics Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for XRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
September 18, 2025 --
February 25, 2025 --
Date Value
December 31, 2024 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Lexaria Bioscience Corp. Upgrade
InMed Pharmaceuticals, Inc. Upgrade
Target Group, Inc. (Canada) --
NervGen Pharma Corp. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade